Los Angeles Cancer Network is a clinical research site located in Glendale, California, United States 91204.
Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.
Los Angeles Cancer Network has participated in 18 clinical trials with 18 currently active.
Therapeutic areas: Non Small Cell Lung Cancer (Squamous or Non Squamous), Stage 4 NSCLC, Essential Thrombocythemia.
Sponsors: Eikon Therapeutics, Merck Sharp & Dohme LLC, Takeda.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Glendale
Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Los Angeles Cancer Network has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Los Angeles Cancer Network has 18 clinical trials on record, with 18 currently active. Their work covers Non Small Cell Lung Cancer (Squamous or Non Squamous), Stage 4 NSCLC, Essential Thrombocythemia.
Los Angeles Cancer Network has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.